Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
In this study, TMEScore can be used as a new prognostic marker to predict the survival of GBM patients, and as a potential predictor of immune checkpoint inhibitor response.
Source: Journal of Molecular Neuroscience - Category: Neuroscience Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Genetics | Immunotherapy | Neurology | Neuroscience | Study